FDA Approval - before 29 July, page-287

I know the the raise was done as they had f all money left. So let’s face it the options are:

a) upcoming ‘fda’ approval is company maker (WOO HOO.. ie what you are being told)

b) actually any FDA approval now it’s not for the actual depression technology which is core business as that won’t be until 2021 at best, but for a random sleep app?!!?

so if a) a massive pump of the shareprice probably warrented
if b) and the qtrly shows minor revenue and you are wondering why people are dumping their shares at 0.012c + that’s because they got them in the raise at 0.006c and have potentially doubled their money already. Maybe

DYOR